Restrepo Dalilah MD is categorized under Infectious Disease Specialists in New York City, NY and active since 1993.
Restrepo Dalilah MD was established in 1993, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Dalilah Restrepo at the company’s single location by writing to 30 West 60th St Apartment An, New York City, New York NY 10023 or by phoning (212) 582-5006. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Restrepo Dalilah MD |
| Contact Person: | Dalilah Restrepo |
| Address: | 30 West 60th St Apartment An, New York City, New York 10023 |
| Phone Number: | (212) 582-5006 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Restrepo Dalilah MD was started in 1993 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dalilah Restrepo for inquiries that concern Restrepo Dalilah MD by calling the company number (212) 582-5006, as your correspondence is most welcome. Additionally, the physical location of the single location of Restrepo Dalilah MD can be found at the coordinates 40.769181,-73.982819 as well as the street address 30 West 60th St Apartment An in New York City, New York 10023.
For its online presence, you may visit Restrepo Dalilah MD’s website at and engage with its social media outlets through on Twitter and on Facebook.